Electrospun Fiber Scaffolds for Pluripotent Stem Cell Expansion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for culturing human embryonic stem cells (hESCs) face challenges such as the need for feeder cells or Matrigel, which can lead to xenocontamination and limit expansion to a two-dimensional environment, making them unsuitable for clinical trials and transplantation.

Innovation Solution

Culturing hESCs on uncoated electrospun fiber scaffolds in a low oxygen atmosphere, without feeder cells or extracellular matrix components, to maintain pluripotency and expand cells in a three-dimensional environment, using synthetic polymers like poly-ε-caprolactone (PCL) with controlled fiber diameter and orientation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If feeder cells or Matrigel are used to culture hESCs, then cell proliferation and maintenance of pluripotency are supported, but xenocontamination occurs and clinical application is limited

Engineering Contradiction:
Improvepluripotency maintenanceVSAvoidxenocontamination
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the harmful feeder cell layer and Matrigel substrate from the culture system, replacing them with a defined synthetic nanofiber scaffold. This eliminates xenocontamination sources while maintaining the structural support needed for hESC proliferation and pluripotency maintenance through controlled nanoscale topography and biochemical signaling.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention changes the physical and chemical parameters of the culture substrate by using synthetic polymers with specific nanoscale fiber diameters (50-500 nm), controlled porosity, and defined biochemical compositions. This replaces the undefined natural substrate with a precisely characterized material that supports hESC growth without xenocontamination.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If traditional 2D culture methods are used, then cell expansion is achieved, but three-dimensional architecture and transplantation readiness are lost

Engineering Contradiction:
Improvecell expansionVSAvoidculture dimensionality
Core Design Contradiction:
ProductivityVSShape

Solution Approach 1:

The invention transitions from two-dimensional flat culture surfaces to three-dimensional nanofiber scaffold structures. The nanofiber network provides vertical and lateral dimensions for cell infiltration, proliferation, and organization, enabling hESCs to form three-dimensional aggregates and maintain architectural complexity suitable for transplantation while achieving robust cell expansion.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Object-affected harmful factors

If synthetic nanofiber scaffolds are used without ECM coating, then xenocontamination is eliminated, but cell adhesion and proliferation may be reduced

Engineering Contradiction:
ImprovexenocontaminationVSAvoidcell proliferation
Core Design Contradiction:
Object-affected harmful factorsVSProductivity

Solution Approach 1:

The invention applies local quality by functionalizing specific regions or surfaces of the nanofiber scaffold with cell-adhesive peptides (such as RGD sequences) or growth factors at controlled densities. This creates localized zones of enhanced adhesion and proliferation signaling on the synthetic scaffold, compensating for the absence of natural ECM while maintaining the overall xeno-free status of the culture system.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS9005607B2Stem cell culture method
Publication Date: 2015.04.14 KEELE UNIVERSITY
  • US9005607B2 patent drawing
  • US9005607B2 patent drawing
  • US9005607B2 patent drawing

AI summary

Methods for culturing pluripotent stem cells on fiber scaffolds are provided which result in the expansion of the number of stem cells without loss of pluripotency. Cells obtained by such methods, implants containing such cells and medical methods using such cells are also disclosed.